WELCOME TO EBRA
The European Brain Research Area, or EBRA, is an EU project coordinated by the European Brain Council (EBC), which launched on 1 November 2018. EBRA was designed to respond to the Horizon 2020 call, SC1-HCO-10-2018, entitled “Coordinating European brain research and developing global initiatives” and will create a catalysing initiative for brain research stakeholders (researchers, clinicians, patients, governments, funders and public institutions) to streamline and better co-ordinate brain research across Europe while fostering global initiatives.
WHO IS EBRA?
EBRA was designed to respond to the Horizon 2020 call, SC1-HCO-10-2018, entitled “Coordinating European brain research and developing global initiatives”, which called for the reduction of fragmentation and duplication of research efforts, fostering synergies through enhanced coordination of brain research efforts at EU and at global level, improved access to and optimising the use of research infrastructures and data sources by the neuroscience research communities, thus ensuring better exploitation of the large investments made in brain research, achieving critical mass and economies of scale by initiating and fostering new global research initiatives, as well a enabling and accelerating the translation of breakthroughs in brain research into relevant clinical applications.
MEET THE PARTNERS
The European Brain Council (EBC) is a non-profit organisation gathering patient associations, major brain-related societies as well as industries. Established in March 2002, its mission is to promote brain research in order to improve the quality of life of those living with brain disorders in Europe.
165 million Europeans are living with a brain disorder, causing a global cost (direct and indirect) exceeding 800 billion euros for the National Health budgets. EBC’s main action areas are:
- Fostering cooperation with its members organisations
- Promoting dialogue between scientists, industry and society
- Interacting with the European Commission, the European Parliament and other relevant international institutions
- Raising awareness and promoting education on the brain
- Disseminating information about brain research and brain diseases in Europe.
The EU Joint Programme – Neurodegenerative Disease Research (JPND) is the largest global research initiative aimed at tackling the challenge of neurodegenerative diseases. JPND aims to increase coordinated investment between participating countries in research aimed at finding causes, developing cures, and identifying appropriate ways to care for those with neurodegenerative diseases.
The ultimate goal of JPND is to find cures for neurodegenerative diseases and to enable early diagnosis for early targeted treatments. However, it is not possible to give definitive predictions on how long this might take to happen.
The ERA-NET NEURON supports basic, clinical and translational research in the diverse fields of disease-related neuroscience. Ministries and funding organisations across Europe, Israel, Turkey and Canada have joined forces to conquer diseases of the brain and the nervous system. According to estimates by the World Health Organisation, more than one billion people suffer from them. Brain diseases are major causes for impaired quality of life. They produced costs of € 800 billion in 2010 and are an increasingly heavy burden on our society. Not just for the patients, but for their families too. In many cases the underlying mechanisms are still not well understood and no curative treatment is available. Thus, neuroscience research and its translation into diagnostic and therapeutic measures are of highest priority for the well-being of patients and their families. The ERA-NET NEURON aims to support research directed at a better understanding of brain diseases and their progression in order to pave the way for new or improved routes for diagnosis and therapy.
The Human Brain Project (HBP) is building a research infrastructure to help advance neuroscience, medicine and computing. It is one of the two largest scientific projects ever funded by the European Union.
The 10-year Project began in 2013 and directly employs some 500 scientists at more than 100 universities, teaching hospitals and research centres across Europe.
Six ICT research Platforms form the heart of the HBP infrastructure: Neuroinformatics (access to shared brain data), Brain Simulation (replication of brain architecture and activity on computers), High Performance Analytics and Computing (providing the required computing and analytics capabilities), Medical Informatics (access to patient data, identification of disease signatures), Neuromorphic Computing (development of brain-inspired computing) and Neurorobotics (use of robots to test brain simulations).
The HBP also undertakes targeted research and theoretical studies, and explores brain structure and function in humans, rodents and other species. In addition, the Project studies the ethical and societal implications of HBP’s work.